Thermo Fisher Scientific Inc. (TMO) Shares Bought by Bank of Montreal Can

Bank of Montreal Can raised its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 16.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 290,892 shares of the medical research company’s stock after buying an additional 40,877 shares during the period. Bank of Montreal Can owned approximately 0.07% of Thermo Fisher Scientific worth $55,235,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Thermo Fisher Scientific by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock valued at $4,640,970,000 after purchasing an additional 629,093 shares in the last quarter. BlackRock Inc. boosted its position in shares of Thermo Fisher Scientific by 1.6% during the 2nd quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock valued at $4,074,828,000 after purchasing an additional 366,584 shares in the last quarter. Capital Research Global Investors boosted its position in shares of Thermo Fisher Scientific by 29.8% during the 2nd quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after purchasing an additional 3,973,136 shares in the last quarter. Capital World Investors boosted its position in shares of Thermo Fisher Scientific by 6.1% during the 2nd quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock valued at $2,051,721,000 after purchasing an additional 671,637 shares in the last quarter. Finally, Longview Partners Guernsey LTD boosted its position in shares of Thermo Fisher Scientific by 7.4% during the 3rd quarter. Longview Partners Guernsey LTD now owns 4,564,913 shares of the medical research company’s stock valued at $863,682,000 after purchasing an additional 313,782 shares in the last quarter. 86.31% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $191.74, for a total value of $9,587,000.00. Following the transaction, the chief executive officer now owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Stephen Williamson sold 5,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $209.26, for a total transaction of $1,046,300.00. Following the completion of the transaction, the chief financial officer now directly owns 30,741 shares in the company, valued at approximately $6,432,861.66. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 144,327 shares of company stock worth $28,680,042. Insiders own 0.49% of the company’s stock.

Several equities analysts have recently weighed in on the stock. ValuEngine upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Bank of America raised their target price on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Morgan Stanley raised their target price on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Barclays raised their target price on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Finally, Leerink Swann reiterated an “outperform” rating and issued a $239.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Thursday, February 1st. They noted that the move was a valuation call. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $220.50.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $1.45 on Friday, reaching $200.18. 2,066,020 shares of the company traded hands, compared to its average volume of 1,680,126. The company has a market capitalization of $80,271.17, a price-to-earnings ratio of 35.75, a PEG ratio of 1.47 and a beta of 1.11. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35. Thermo Fisher Scientific Inc. has a 52-week low of $151.74 and a 52-week high of $226.44.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating the consensus estimate of $2.66 by $0.13. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.41 earnings per share. research analysts expect that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Thursday, March 15th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.71%.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc. (TMO) Shares Bought by Bank of Montreal Can” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://ledgergazette.com/2018/02/12/bank-of-montreal-can-has-55-24-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply